Custom Antibody Market by Service (Antibody Development, Production, Labelling), Type (Monoclonal, Polyclonal, Recombinant), Source (Rabbit, Mice), Research Area (Oncology, Immunology), End User (Pharmaceutical Companies, CRO's) - Global Industry Analysis, Share ,Growth ,Regional Outlook And Forecasts, 2021-2027

The global Custom Antibody market gathered revenue around USD 345 million in 2020 and market is set to grow USD 700 million by the end of 2027 and is estimated to expand at a modest CAGR of 12% during the prediction period 2021 to 2027. As such, an increase in research activity-especially in the life sciences industry-along with growing industry-academia collaborations are the primary growth drivers for this market. In addition, the objective behind custom antibody production is to acquire an antibody that performs well in a particular qualitative or quantitative immunodetection method. The quality of catalog antibodies (to ensure the reproducibility of results) is also an area of concern in this market, which is primarily why end users prefer custom-made antibodies.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Custom Antibody market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Custom Antibody market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Custom Antibody market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

North America accounted for the largest share of the custom antibody market in 2020.

The custom antibody market is broadly segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share in the custom antibody market. The large share of this region can be attributed to the increasing investments in the development of structure-based drug designs, growing research in the fields of genomics and proteomics, rising demand for high-quality research tools for data reproducibility, and the increasing focus on developing antibody-based therapeutics. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Significant Market Participants Operational in the Custom Antibody Market are:

The major market players include  as Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck Group (Germany), Cell Signaling Technology, Inc. (US), GenScript (China), BioLegend (US), Rockland Immunochemicals (US)

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

The study categorizes the custom antibody market into the following segments and subsegments:

by Service

  • Antibody Development
  • Antibody Production & Purification
  • Antibody Fragmentation & Labeling

by Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
  • Other Custom Antibodies

by Source

  • Mice
  • Rabbits
  • Other Sources

by Research Area

  • Oncology
  • Infectious Diseases
  • Neurobiology
  • Stem Cells
  • Immunology
  • Cardiovascular Disease
  • Other Research Areas

by End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Custom Antibody Market, By Service

7.1.  Custom Antibody Market, by Service, 2021-2027

7.1.1.     Antibody Development

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Antibody Production & Purification

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Antibody Fragmentation & Labeling

7.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Custom Antibody Market, By Type

8.1.  Custom Antibody Market, by Type, 2021-2027

8.1.1.     Monoclonal Antibodies

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Polyclonal Antibodies

8.1.2.1.          Market Revenue and Forecast (2016-2027)

8.1.3.     Recombinant Antibodies

8.1.3.1.          Market Revenue and Forecast (2016-2027)

8.1.4.     Other Custom Antibodies

8.1.4.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Custom Antibody Market, By Source

9.1.  Custom Antibody Market, by Source, 2021-2027

9.1.1.     Mice

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Rabbits

9.1.2.1.          Market Revenue and Forecast (2016-2027)

9.1.3.     Other Sources

9.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global Custom Antibody Market, By Research Area

10.1.          Custom Antibody Market, by Research Area, 2021-2027

10.1.1.  Oncology

10.1.1.1.       Market Revenue and Forecast (2016-2027)

10.1.2.  Infectious Diseases

10.1.2.1.       Market Revenue and Forecast (2016-2027)

10.1.3.  Neurobiology

10.1.3.1.       Market Revenue and Forecast (2016-2027)

10.1.4.  Stem Cells

10.1.4.1.       Market Revenue and Forecast (2016-2027)

10.1.5.  Immunology

10.1.5.1.       Market Revenue and Forecast (2016-2027)

10.1.6.  Cardiovascular Disease

10.1.6.1.       Market Revenue and Forecast (2016-2027)

10.1.7.  Other Research Areas

10.1.7.1.       Market Revenue and Forecast (2016-2027)

Chapter 11.Global Custom Antibody Market, By End User

11.1.          Custom Antibody Market, by End User, 2021-2027

11.1.1.  Pharmaceutical & Biotechnology Companies

11.1.1.1.       Market Revenue and Forecast (2016-2027)

11.1.2.  Academic & Research Institutes

11.1.2.1.       Market Revenue and Forecast (2016-2027)

11.1.3.  Contract Research Organizations

11.1.3.1.       Market Revenue and Forecast (2016-2027)

Chapter 12.Global Custom Antibody Market, Regional Estimates and Trend Forecast

12.1.          North America

12.1.1.  Market Revenue and Forecast, by Service (2016-2027)

12.1.2.  Market Revenue and Forecast, by Type (2016-2027)

12.1.3.  Market Revenue and Forecast, by Source (2016-2027)

12.1.4.  Market Revenue and Forecast, by Research Area (2016-2027)

12.1.5.  Market Revenue and Forecast, by End User (2016-2027)

12.1.6.  U.S.

12.1.6.1.       Market Revenue and Forecast, by Service (2016-2027)

12.1.6.2.       Market Revenue and Forecast, by Type (2016-2027)

12.1.6.3.       Market Revenue and Forecast, by Source (2016-2027)

12.1.6.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.1.6.5.       Market Revenue and Forecast, by End User (2016-2027)

12.1.7.  Rest of North America

12.1.7.1.       Market Revenue and Forecast, by Service (2016-2027)

12.1.7.2.       Market Revenue and Forecast, by Type (2016-2027)

12.1.7.3.       Market Revenue and Forecast, by Source (2016-2027)

12.1.7.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.1.7.5.       Market Revenue and Forecast, by End User (2016-2027)

12.2.          Europe

12.2.1.  Market Revenue and Forecast, by Service (2016-2027)

12.2.2.  Market Revenue and Forecast, by Type (2016-2027)

12.2.3.  Market Revenue and Forecast, by Source (2016-2027)

12.2.4.  Market Revenue and Forecast, by Research Area (2016-2027)

12.2.5.  Market Revenue and Forecast, by End User (2016-2027)

12.2.6.  UK

12.2.6.1.       Market Revenue and Forecast, by Service (2016-2027)

12.2.6.2.       Market Revenue and Forecast, by Type (2016-2027)

12.2.6.3.       Market Revenue and Forecast, by Source (2016-2027)

12.2.6.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.2.6.5.       Market Revenue and Forecast, by End User (2016-2027)

12.2.7.  Germany

12.2.7.1.       Market Revenue and Forecast, by Service (2016-2027)

12.2.7.2.       Market Revenue and Forecast, by Type (2016-2027)

12.2.7.3.       Market Revenue and Forecast, by Source (2016-2027)

12.2.7.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.2.7.5.       Market Revenue and Forecast, by End User (2016-2027)

12.2.8.  France

12.2.8.1.       Market Revenue and Forecast, by Service (2016-2027)

12.2.8.2.       Market Revenue and Forecast, by Type (2016-2027)

12.2.8.3.       Market Revenue and Forecast, by Source (2016-2027)

12.2.8.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.2.8.5.       Market Revenue and Forecast, by End User (2016-2027)

12.2.9.  Rest of Europe

12.2.9.1.       Market Revenue and Forecast, by Service (2016-2027)

12.2.9.2.       Market Revenue and Forecast, by Type (2016-2027)

12.2.9.3.       Market Revenue and Forecast, by Source (2016-2027)

12.2.9.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.2.9.5.       Market Revenue and Forecast, by End User (2016-2027)

12.3.          APAC

12.3.1.  Market Revenue and Forecast, by Service (2016-2027)

12.3.2.  Market Revenue and Forecast, by Type (2016-2027)

12.3.3.  Market Revenue and Forecast, by Source (2016-2027)

12.3.4.  Market Revenue and Forecast, by Research Area (2016-2027)

12.3.5.  Market Revenue and Forecast, by End User (2016-2027)

12.3.6.  India

12.3.6.1.       Market Revenue and Forecast, by Service (2016-2027)

12.3.6.2.       Market Revenue and Forecast, by Type (2016-2027)

12.3.6.3.       Market Revenue and Forecast, by Source (2016-2027)

12.3.6.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.3.6.5.       Market Revenue and Forecast, by End User (2016-2027)

12.3.7.  China

12.3.7.1.       Market Revenue and Forecast, by Service (2016-2027)

12.3.7.2.       Market Revenue and Forecast, by Type (2016-2027)

12.3.7.3.       Market Revenue and Forecast, by Source (2016-2027)

12.3.7.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.3.7.5.       Market Revenue and Forecast, by End User (2016-2027)

12.3.8.  Japan

12.3.8.1.       Market Revenue and Forecast, by Service (2016-2027)

12.3.8.2.       Market Revenue and Forecast, by Type (2016-2027)

12.3.8.3.       Market Revenue and Forecast, by Source (2016-2027)

12.3.8.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.3.8.5.       Market Revenue and Forecast, by End User (2016-2027)

12.3.9.  Rest of APAC

12.3.9.1.       Market Revenue and Forecast, by Service (2016-2027)

12.3.9.2.       Market Revenue and Forecast, by Type (2016-2027)

12.3.9.3.       Market Revenue and Forecast, by Source (2016-2027)

12.3.9.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.3.9.5.       Market Revenue and Forecast, by End User (2016-2027)

12.4.          MEA

12.4.1.  Market Revenue and Forecast, by Service (2016-2027)

12.4.2.  Market Revenue and Forecast, by Type (2016-2027)

12.4.3.  Market Revenue and Forecast, by Source (2016-2027)

12.4.4.  Market Revenue and Forecast, by Research Area (2016-2027)

12.4.5.  Market Revenue and Forecast, by End User (2016-2027)

12.4.6.  GCC

12.4.6.1.       Market Revenue and Forecast, by Service (2016-2027)

12.4.6.2.       Market Revenue and Forecast, by Type (2016-2027)

12.4.6.3.       Market Revenue and Forecast, by Source (2016-2027)

12.4.6.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.4.6.5.       Market Revenue and Forecast, by End User (2016-2027)

12.4.7.  North Africa

12.4.7.1.       Market Revenue and Forecast, by Service (2016-2027)

12.4.7.2.       Market Revenue and Forecast, by Type (2016-2027)

12.4.7.3.       Market Revenue and Forecast, by Source (2016-2027)

12.4.7.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.4.7.5.       Market Revenue and Forecast, by End User (2016-2027)

12.4.8.  South Africa

12.4.8.1.       Market Revenue and Forecast, by Service (2016-2027)

12.4.8.2.       Market Revenue and Forecast, by Type (2016-2027)

12.4.8.3.       Market Revenue and Forecast, by Source (2016-2027)

12.4.8.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.4.8.5.       Market Revenue and Forecast, by End User (2016-2027)

12.4.9.  Rest of MEA

12.4.9.1.       Market Revenue and Forecast, by Service (2016-2027)

12.4.9.2.       Market Revenue and Forecast, by Type (2016-2027)

12.4.9.3.       Market Revenue and Forecast, by Source (2016-2027)

12.4.9.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.4.9.5.       Market Revenue and Forecast, by End User (2016-2027)

12.5.          Latin America

12.5.1.  Market Revenue and Forecast, by Service (2016-2027)

12.5.2.  Market Revenue and Forecast, by Type (2016-2027)

12.5.3.  Market Revenue and Forecast, by Source (2016-2027)

12.5.4.  Market Revenue and Forecast, by Research Area (2016-2027)

12.5.5.  Market Revenue and Forecast, by End User (2016-2027)

12.5.6.  Brazil

12.5.6.1.       Market Revenue and Forecast, by Service (2016-2027)

12.5.6.2.       Market Revenue and Forecast, by Type (2016-2027)

12.5.6.3.       Market Revenue and Forecast, by Source (2016-2027)

12.5.6.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.5.6.5.       Market Revenue and Forecast, by End User (2016-2027)

12.5.7.  Rest of LATAM

12.5.7.1.       Market Revenue and Forecast, by Service (2016-2027)

12.5.7.2.       Market Revenue and Forecast, by Type (2016-2027)

12.5.7.3.       Market Revenue and Forecast, by Source (2016-2027)

12.5.7.4.       Market Revenue and Forecast, by Research Area (2016-2027)

12.5.7.5.       Market Revenue and Forecast, by End User (2016-2027)

Chapter 13.   Company Profiles

13.1.                 Thermo Fisher Scientific, Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.                 Bio-Rad Laboratories, Inc.

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.                 Merck Group

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.                 Cell Signaling Technology, Inc.

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.                 GenScript

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.                 BioLegend

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.                 Rockland Immunochemicals 

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

Chapter 14.   Research Methodology

14.1.                 Primary Research

14.2.                 Secondary Research

14.3.                 Assumptions

Chapter 15.   Appendix

15.1.                 About Us

15.2.                 Glossary of Terms

Proceed To Buy

USD 4500
USD 3900
USD 1900
USD 1200

Customization Offered

  • check-img Cross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers